Big pharma companies announce FDA approval of Eliquis for DVT prophylaxis

Posted On 19 Mar 2014
By :

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Eliquis for the prophylaxis of deep vein thrombosis , which may lead to pulmonary embolism in patients who have undergone hip or knee replacement surgery.

Read the source article at Topix: Your town. Your news. Your take.

About the Author

Leave a Reply